Charge-discriminating antimicrobial coacervates and uses thereof
Publish time: 2025-01-02 00:00:00
Charge-discriminating antimicrobial coacervates and uses thereof
Docket Number
12A-1130808
IP Status
USP patent pending
Abstract
The invention is a first –in- class antimicrobial peptide formulation. It effectively addresses the intravenous delivery challenge associated with cationic A<MPs and is proven to eradicate multidrug resistant bacteria in the bloodstream.
Technological Advantages
- The melittin coacervate shown in the embodiment addressed the long-standing challenge of limited intravenous applicability of antimicrobial peptides.
- We show the intravenous formulation is more effective than clinical antibiotics standard for treating multidrug resistant bacteria.
Applications of Technology
- Pharmaceutical antibiotics formulation for intravenous delivery
- Pharmaceutical antibiotics formulation for topical delivery
Inventor
Che-Ming (Jack) Hu
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Charge-discriminating antimicrobial coacervates and uses thereof